Recommended Dosages of Analgesic and Sedative Drugs in Intensive Care Result in a Low Incidence of Potentially Toxic Blood Concentrations

Overview

Journal Ups J Med Sci

Specialty General Medicine

Date 2024 Jun 12

PMID 38863729

Authors

Ulrica Lennborn

Anna Johansson

Erik Lindgren

Elisabet I Nielsen

Hakan Sandler

Maria Bertilsson

Robert Kronstrand

Johan Ahlner

Fredrik C Kugelberg

Sten Rubertsson

Affiliations

Soon will be listed here.

Abstract

Background: Standard dosages of analgesic and sedative drugs are given to intensive care patients. The resulting range of blood concentrations and corresponding clinical responses need to be better examined. The purpose of this study was to describe daily dosages, measured blood concentrations, and clinical responses in critically ill patients. The purpose was also to contribute to establishing whole blood concentration reference values of the drugs investigated.

Methods: A descriptive study of prospectively collected data from 302 admissions to a general intensive care unit (ICU) at a university hospital. Ten drugs (clonidine, fentanyl, morphine, dexmedetomidine, ketamine, ketobemidone, midazolam, paracetamol, propofol, and thiopental) were investigated, and daily dosages recorded. Blood samples were collected twice daily, and drug concentrations were measured. Clinical responses were registered using Richmond agitation-sedation scale (RASS) and Numeric rating scale (NRS).

Results: Drug dosages were within recommended dose ranges. Blood concentrations for all 10 drugs showed a wide variation within the cohort, but only 3% were above therapeutic interval where clonidine (57 of 122) and midazolam (38 of 122) dominated. RASS and NRS were not correlated to drug concentrations.

Conclusion: Using recommended dose intervals for analgesic and sedative drugs in the ICU setting combined with regular monitoring of clinical responses such as RASS and NRS leads to 97% of concentrations being below the upper limit in the therapeutic interval. This study contributes to whole blood drug concentration reference values regarding these 10 drugs.

References

Bremer F, Reulbach U, Schwilden H, Schuttler J . Midazolam therapeutic drug monitoring in intensive care sedation: a 5-year survey. Ther Drug Monit. 2004; 26(6):643-9. DOI: 10.1097/00007691-200412000-00010. View

Varney Gill K, Voils S, Chenault G, Brophy G . Perceived versus actual sedation practices in adult intensive care unit patients receiving mechanical ventilation. Ann Pharmacother. 2012; 46(10):1331-9. DOI: 10.1345/aph.1R037. View

Williamson A, Hoggart B . Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005; 14(7):798-804. DOI: 10.1111/j.1365-2702.2005.01121.x. View

Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S . Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care. 2020; 24(1):195. PMC: 7201985. DOI: 10.1186/s13054-020-02915-5. View

Gerlach A, Murphy C . Sedation with dexmedetomidine in the intensive care setting. Open Access Emerg Med. 2016; 3:77-85. PMC: 4753994. DOI: 10.2147/OAEM.S17429. View

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310(20):2191-4. DOI: 10.1001/jama.2013.281053. View

Kirwan C, Lee T, Holt D, Grounds R, MacPhee I, Philips B . Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients. Intensive Care Med. 2009; 35(7):1271-5. DOI: 10.1007/s00134-009-1430-7. View

Wesley Ely E, Truman B, Shintani A, Thomason J, Wheeler A, Gordon S . Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003; 289(22):2983-91. DOI: 10.1001/jama.289.22.2983. View

Kollef M, Levy N, Ahrens T, Schaiff R, Prentice D, Sherman G . The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998; 114(2):541-8. DOI: 10.1378/chest.114.2.541. View

10.

Metnitz P, Moreno R, Almeida E, Jordan B, Bauer P, Abizanda Campos R . SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005; 31(10):1336-44. PMC: 1315314. DOI: 10.1007/s00134-005-2762-6. View

11.

Swart E, Zuideveld K, de Jongh J, Danhof M, Thijs L, Strack van Schijndel R . Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. Eur J Clin Pharmacol. 2006; 62(3):185-94. DOI: 10.1007/s00228-005-0085-8. View

12.

Tse A, Ling L, Lee A, Joynt G . Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review. Clin Ther. 2018; 40(9):1598-1615.e2. DOI: 10.1016/j.clinthera.2018.07.021. View

13.

Hannivoort L, Absalom A, Struys M . The role of pharmacokinetics and pharmacodynamics in clinical anaesthesia practice. Curr Opin Anaesthesiol. 2020; 33(4):483-489. DOI: 10.1097/ACO.0000000000000881. View

14.

Minto C, Schnider T . Contributions of PK/PD modeling to intravenous anesthesia. Clin Pharmacol Ther. 2008; 84(1):27-38. DOI: 10.1038/clpt.2008.100. View

15.

Nies R, Muller C, Pfister R, Binder P, Nosseir N, Nettersheim F . Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients. J Intensive Care. 2018; 6:62. PMC: 6137863. DOI: 10.1186/s40560-018-0331-7. View

16.

Barr J, Fraser G, Puntillo K, Wesley Ely E, Gelinas C, Dasta J . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2012; 41(1):263-306. DOI: 10.1097/CCM.0b013e3182783b72. View

17.

Porhomayon J, Joude P, Adlparvar G, El-Solh A, Nader N . The Impact of High Versus Low Sedation Dosing Strategy on Cognitive Dysfunction in Survivors of Intensive Care Units: A Systematic Review and Meta-Analysis. J Cardiovasc Thorac Res. 2015; 7(2):43-8. PMC: 4492176. DOI: 10.15171/jcvtr.2015.10. View

18.

Roman M, Strom L, Tell H, Josefsson M . Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening. Anal Bioanal Chem. 2013; 405(12):4107-25. DOI: 10.1007/s00216-013-6798-0. View

19.

Masica A, Girard T, Wilkinson G, Thomason J, Pun B, Nair U . Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients. Am J Geriatr Pharmacother. 2007; 5(3):218-31. DOI: 10.1016/j.amjopharm.2007.10.005. View

20.

Pearson S, Patel B . Evolving targets for sedation during mechanical ventilation. Curr Opin Crit Care. 2019; 26(1):47-52. PMC: 8086012. DOI: 10.1097/MCC.0000000000000687. View